These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 15140391
1. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. Microb Drug Resist; 2004; 10(1):31-6. PubMed ID: 15140391 [Abstract] [Full Text] [Related]
2. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family. Florindo C, Viegas S, Paulino A, Rodrigues E, Gomes JP, Borrego MJ. Clin Microbiol Infect; 2010 Sep; 16(9):1458-63. PubMed ID: 19886900 [Abstract] [Full Text] [Related]
3. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P. Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524 [Abstract] [Full Text] [Related]
4. [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae]. Martínez MA, Ovalle A, Durán C, Reid I, Urriola G, Garay B, Cifuentes M. Rev Med Chil; 2004 May; 132(5):549-55. PubMed ID: 15279140 [Abstract] [Full Text] [Related]
5. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Schoening TE, Wagner J, Arvand M. Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978 [Abstract] [Full Text] [Related]
6. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924 [Abstract] [Full Text] [Related]
7. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [Abstract] [Full Text] [Related]
9. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)]. Campelo FA, Pedrosa AC, Antúnez IÁ, Capuz BL. Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541 [Abstract] [Full Text] [Related]
10. Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants. Otaguiri ES, Morguette AE, Tavares ER, dos Santos PM, Morey AT, Cardoso JD, Perugini MR, Yamauchi LM, Yamada-Ogatta SF. BMC Microbiol; 2013 Dec 21; 13():297. PubMed ID: 24359590 [Abstract] [Full Text] [Related]
11. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. Domelier AS, van der Mee-Marquet N, Arnault L, Mereghetti L, Lanotte P, Rosenau A, Lartigue MF, Quentin R. J Antimicrob Chemother; 2008 Dec 21; 62(6):1227-33. PubMed ID: 18786936 [Abstract] [Full Text] [Related]
12. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. Ergin A, Ercis S, Hasçelik G. J Antimicrob Chemother; 2006 Jan 21; 57(1):139-41. PubMed ID: 16291867 [Abstract] [Full Text] [Related]
13. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Antimicrob Agents Chemother; 2001 Dec 21; 45(12):3504-8. PubMed ID: 11709331 [Abstract] [Full Text] [Related]
14. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia. Hraoui M, Boutiba-Ben Boubaker I, Rachdi M, Slim A, Ben Redjeb S. J Med Microbiol; 2012 Aug 21; 61(Pt 8):1109-1113. PubMed ID: 22538994 [Abstract] [Full Text] [Related]
15. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan. Ko WC, Yan JJ, Lee NY, Wu HM, Wu JJ. Microb Drug Resist; 2004 Aug 21; 10(4):306-12. PubMed ID: 15650375 [Abstract] [Full Text] [Related]
16. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Silva-Costa C, Pinto FR, Ramirez M, Melo-Cristino J, Portuguese Surveillance Group for the Study of Respiratory Pathogens. Clin Microbiol Infect; 2008 Dec 21; 14(12):1152-9. PubMed ID: 19046174 [Abstract] [Full Text] [Related]
18. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Imperi M, Gherardi G, Berardi A, Baldassarri L, Pataracchia M, Dicuonzo G, Orefici G, Creti R. Clin Microbiol Infect; 2011 Dec 21; 17(12):1834-9. PubMed ID: 21722258 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Souza VC, Kegele FC, Souza SR, Neves FP, de Paula GR, Barros RR. Scand J Infect Dis; 2013 Oct 21; 45(10):780-5. PubMed ID: 23876189 [Abstract] [Full Text] [Related]
20. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Nakamura PA, Schuab RB, Neves FP, Pereira CF, Paula GR, Barros RR. Mem Inst Oswaldo Cruz; 2011 Mar 21; 106(2):119-22. PubMed ID: 21537668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]